Lichter Jay's Form 4 filing
Janux Therapeutics, Inc. (JANX) · filed Oct 24, 2024
- Accession no.
- 0001415889-24-025601
- Filed
- Oct 24, 2024
- Trade date
- Sep 13, 2024
- Filing delay
- 41 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $178.1K. It was filed 41 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lichter JayCIK 0001376355 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | Common Stock | MOption exerciseAcquired | +1,868 | $17.00 | +$31,756 | 8,868 | Direct | |
| Sep 13, 2024 | Common Stock | MOption exerciseAcquired | +778 | $10.73 | +$8,347.94 | 9,646 | Direct | |
| Sep 13, 2024 | Common Stock | MOption exerciseAcquired | +778 | $13.22 | +$10,285.16 | 10,424 | Direct | |
| Sep 13, 2024 | Common Stock | MOption exerciseAcquired | +391 | $39.80 | +$15,561.8 | 10,815 | Direct | |
| Sep 13, 2024 | Common Stock | SSaleDisposed | −3,815 | $46.68 | −$178,084.2 | 7,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | Common Stock | MOption exerciseDisposed | −1,868 | $0.00 | $0 | 27,138 | Direct | |
| Sep 13, 2024 | Common Stock | MOption exerciseDisposed | −778 | $0.00 | $0 | 11,308 | Direct | |
| Sep 13, 2024 | Common Stock | MOption exerciseDisposed | −778 | $0.00 | $0 | 11,308 | Direct | |
| Sep 13, 2024 | Common Stock | MOption exerciseDisposed | −391 | $0.00 | $0 | 7,682 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.